1 Summary
2 Categories and market overview
2.1 CCB (calcium-channel blocker)
2.2 ACEI （angiotensin-converting enzyme inhibitor）
2.3 ARBs (angiotensin Ⅱ receptor blocker)
2.4 β-blocker
2.5 α-blocker
2.6 Diuretic
2.7 Others
3 Sales analysis of the past 4 years
3.1 Market scale and growth trend
3.2 Market share and change trend
3.2.1 Sales shares of different products of Antihypertensive Drugs
3.2.2 Sales shares of different products of CCB
3.2.3 Sales shares of different products of ACEI
3.2.4 Sales shares of different products of ARBs
3.2.5 Sales shares of different products of β-blocker
3.2.6 Sales shares of different products of α-blocker
3.2.7 Sales shares of different products of diuretic
3.2.8 Others
3.3 Change about sales rank of key brands
4 Market analysis of last year
4.1 Sales shares of different products
4.2 Sales shares of different brands
4.3 Key products and competitive enterprises of CCB
Amlodipine
Nifedipine
Felodipine
Nimodipine
levamlodipine
Nitrendipine
Nisoldipine
Others
4.4 Key products and competitive enterprises of ACEI
Benazepril
Enalapril
Captopril
Lysinopril
Ramipril
Compound Captopril
Others
4.5 Key products and competitive enterprises of ARBs
Losartan
Valsartan
Irbesartan
Telmisartan
Candesartan
Coumpand preparation
4.6 Key products and competitive enterprises of β-blocker
4.7 Key products and competitive enterprises of α-blocker
4.8 Key products and competitive enterprises of α-blocker
4.9 Key products and competitive enterprises of Diuretic
5 Sales analysi of key cities
6 Research and development in China
6.1 Lsit of Domestic marketd products and import procucts
6.2 Status of application and approval for Blood Thinning Drugs
中文
